Y Miki, 1994, Science, 266, 66, 10.1126/science.7545954
R Wooster, 1995, Nature, 378, 789, 10.1038/378789a0
MA Blackwood, 1998, J Clin Oncol, 16, 1969, 10.1200/JCO.1998.16.5.1969
JR Smith, 1996, Science, 274, 1371, 10.1126/science.274.5291.1371
J Xu, 1998, Nat Genet, 20, 175, 10.1038/2477
D Ford, 1994, Lancet, 343, 692, 10.1016/S0140-6736(94)91578-4
M Gibbs, 1999, Am J Hum Genet, 64, 776, 10.1086/302287
P Berthon, 1998, Am J Hum Genet, 62, 1416, 10.1086/301879
SV Tavtigian, 2001, Nat Genet, 27, 172, 10.1038/84808
K Nathanson, 2001, Hum Mol Genet, 10, 715, 10.1093/hmg/10.7.715
PD Pharoah, 2002, Nat Genet, 31, 33, 10.1038/ng853
R Wooster, 1995, Nature, 378, 789, 10.1038/378789a0
J Charrier, 1999, Br J Cancer, 79, 346, 10.1038/sj.bjc.6690055
M Bergman-Jungestrom, 1999, Int J Cancer, 84, 350, 10.1002/(SICI)1097-0215(19990820)84:4<350::AID-IJC3>3.0.CO;2-L
AM Dunning, 1999, Cancer Epidemiol Biomark Prev, 8, 843
AC Bateman, 1999, J Pathol, 188, 231, 10.1002/(SICI)1096-9896(199907)188:3<231::AID-PATH325>3.0.CO;2-A
J Bidwell, 1999, Genes Immun, 1, 3, 10.1038/sj.gene.6363645
Haukim N, Bidwell JL, Smith AJP, et al. Cytokine gene polymorphism in human disease: on-line databases, Supplement 2. Genes Immun 2002; 313–30
J Demeter, 1997, Br J Haematol, 97, 107, 10.1046/j.1365-2141.1997.9912636.x
K Warzocha, 1998, Blood, 91, 3574, 10.1182/blood.V91.10.3574
S Mestiri, 2001, Cancer, 91, 672, 10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J
C Wihlborg, 1999, Br J Haematol, 104, 346, 10.1046/j.1365-2141.1999.01176.x
KS Park, 2002, Eur J Immunogenet, 29, 7, 10.1046/j.0960-7420.2001.00260.x
EM El-Omar, 2000, Nature, 404, 398, 10.1038/35006081
J Eskdale, 1997, Immunogenetics, 46, 120, 10.1007/s002510050250
Howell WM. Interleukin-10 gene polymorphisms and cancer. In Marincola FM, (ed): Interleukin-10. Eurekah.com; pp. 1–17
DM Turner, 1997, Eur J Immunogenetics, 24, 1, 10.1111/j.1365-2370.1997.tb00001.x
E Crawley, 1999, Arthritis Rheum, 42, 1101, 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y
SC Hoffman, 2001, Transplantation, 72, 1444, 10.1097/00007890-200110270-00019
E Reuss, 2002, Genes Immun, 3, 407, 10.1038/sj.gene.6363920
J Eskdale, 1998, Proc Natl Acad Sci USA, 95, 9465, 10.1073/pnas.95.16.9465
RG Westendorp, 1997, Lancet, 349, 170, 10.1016/S0140-6736(96)06413-6
WM Howell, 2001, Genes and Immun, 2, 25, 10.1038/sj.gene.6363726
JA Martinez-Escribano, 2002, Melanoma Res, 12, 465, 10.1097/00008390-200209000-00008
SL McCarron, 2002, Cancer Res, 62, 3369
KC Smith, 2004, Eur J Immunogenet, 31, 167, 10.1111/j.1365-2370.2004.00462.x
L Giordani, 2004, Clin Chem, 49, 1664, 10.1373/49.10.1664
U Langsenlehner, 2005, Breast Cancer Res Treat, 90, 113, 10.1007/s10549-004-3607-7
EA Bulpitt, 2004, Genes Immun, 5, S53
GA Stanczuk, 2001, Int J Cancer, 94, 792, 10.1002/ijc.1543
JW Roh, 2002, Cancer Lett, 184, 57, 10.1016/S0304-3835(02)00193-3
M-S Wu, 2003, Int J Cancer, 104, 617, 10.1002/ijc.10987
M-S Wu, 2002, J Infect Dis, 185, 106, 10.1086/324771
EM El-Omar, 2003, Gastroenterology, 124, 1193, 10.1016/S0016-5085(03)00157-4
E Alamartine, 2003, J Invest Dermatol, 120, 99, 10.1046/j.1523-1747.2003.12016.x
HD Shin, 2003, Hum Mol Genet, 12, 901, 10.1093/hmg/ddg104
Havranek E, Howell WM, Fussell HM, Whelan JA, Whelan MA, Pandha HS. An IL-10 promoter polymorphism may influence tumour development in renal cell carinoma. J Urol 2005; 173: 709–12
C Zheng, 2001, Int J Cancer, 95, 184, 10.1002/1097-0215(20010520)95:3<184::AID-IJC1031>3.0.CO;2-V
D Gowans, 2002, Br J Haematol, 117, 541, 10.1046/j.1365-2141.2002.03452.x
LM Cunningham, 2003, Leukemia Lymphoma, 44, 251, 10.1080/1042819021000035590
EC Breen, 2003, Clin Immunol, 109, 119, 10.1016/S1521-6616(03)00214-6
E Lech-Maranda, 2004, Blood, 103, 3529, 10.1182/blood-2003-06-1850
LR Munro, 2003, Leukemia & Lymphoma, 44, 2083, 10.1080/1042819031000119316
M Lauten, 2002, Leukemia, 16, 1437, 10.1038/sj.leu.2402545
A DeMichele, 2003, Cancer Res, 15, 8051
LS Ito, 2002, Jpn J Clin Oncol, 32, 398, 10.1093/jjco/hyf081
A Saha, 2004, Eur J Immunogenet, 31, 37, 10.1111/j.1365-2370.2004.00442.x
KM Lee, 2005, Breast Cancer Res Treat, 90, 149, 10.1007/s10549-004-3859-2
AM Dunning, 2003, Cancer Res, 63, 2610
JH Barrett, 2000, Histocompatibility Testing, 439, 10.1142/9781848160507_0027
